SCHEMBL19863041

SCHEMBL19863041

c1ccc(-c2ccc(-c3nc(-c4ccccc4)nc(-c4ccc(-n5c6ccccc6c6c7oc8ccccc8c7cc(-c7ccc8c(c7)c7ccccc7n8-c7ccccc7)c65)cc4)n3)cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.34
ATM Q13315 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
PTGER4 P35408 1/20 0.33
MAPT P10636 4/20 0.32
ALDH1A1 P00352 4/20 0.32
TSHR P16473 3/20 0.32
HSD17B10 Q99714 2/20 0.32
POLB P06746 2/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
BRCA1 P38398 1/20 0.32
SIRT2 Q8IXJ6 1/20 0.31
SIRT1 Q96EB6 1/20 0.31
ALOX5 P09917 1/20 0.31
LMNA P02545 3/20 0.31
MAPK1 P28482 1/20 0.31
HPGD P15428 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.30
PTGER1 P34995 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18593673 0.99 KDM4E (0.35) KDM4EATML3MBTL1PTGER4MAPT
SCHEMBL19863052 0.95 KDM4E (0.32) KDM4EATML3MBTL1PTGER4MAPT
SCHEMBL19862981 0.95 KDM4E (0.33) KDM4EATML3MBTL1PTGER4MAPT
SCHEMBL18594178 0.94 KDM4E (0.33) KDM4EATML3MBTL1PTGER4MAPT
SCHEMBL19862979 0.94 KDM4E (0.34) KDM4EATML3MBTL1PTGER4MAPT
SCHEMBL19863165 0.94 KDM4E (0.34) KDM4EATML3MBTL1PTGER4MAPT
SCHEMBL19863047 0.94 KDM4E (0.34) KDM4EATML3MBTL1MAPTALDH1A1
SCHEMBL18594157 0.94 KDM4E (0.38) KDM4EATML3MBTL1ALDH1A1TSHR
SCHEMBL19863042 0.93 KDM4E (0.35) KDM4EATML3MBTL1MAPTALDH1A1
SCHEMBL19863163 0.93 KDM4E (0.33) KDM4EATML3MBTL1MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10230056-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2019-03-12 US disclosed
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-02-15 US disclosed
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10230056-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, NR2E3 KDM4E 1039/4885ATM 2081/4885L3MBTL1 622/4885
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, NR2E3 KDM4E 1039/4885ATM 2081/4885L3MBTL1 622/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.